Ikonisys secured EUR 2.72 million through a capital increase and debt conversion, led by Avantgarde Srl and Alberto Previtali, to enhance its cancer detection solutions.
Amount Raised
€2.72 Million
Round Type
Funding Round
ParigiBiotechnologyHealth CareInvestors
Description
Ikonisys SA recently announced a capital increase in cash for €1.5 million, alongside a request to convert €1.22 million of existing debt into capital. This funding round, totaling €2.72 million, aims to bolster its innovative medical analysis laboratory solutions. High-profile investors include Avantgarde and Alberto Previtali, supporting the company's growth vision. The funds will enhance Ikonisys's position in the healthcare sector.
Quick answer
Ikonisys raised €2.72 Million in a Funding Round round, dated December 19, 2025. Investors: Avantgarde Srl and Alberto Previtali. Ikonisys is based in Parigi, Ile De France, France.
- How much did Ikonisys raise?
- Ikonisys raised €2.72 Million in a Funding Round round on December 19, 2025.
- Who invested in Ikonisys?
- Avantgarde Srl and Alberto Previtali are named as investors in this round.
- What does Ikonisys do?
- Ikonisys is a global leader in automated diagnostics, specializing in fluorescence in situ hybridization (FISH) and circulating tumor cell (CTC) detection.
- Where is Ikonisys based and how big is it?
- Ikonisys is based in Parigi, Ile De France, France. Fundz records about 40 employees.
- Who are the decision-makers at Ikonisys?
- Fundz holds 2 contacts at Ikonisys, including the CFO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Ikonisys that raised within 45 days of this round, from Fundz verified event records.
- Biorce raised $52M (Series A) on February 2, 2026.
- CytoDyn raised $19M on January 30, 2026.
- ORamaVR raised $4.5M (Seed) on January 30, 2026.
- Richtech Robotics raised $39M (Post-IPO Equity) on January 29, 2026.
- Biopeak raised $2.7M (Seed) on January 29, 2026.
- Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
Who to call at Ikonisys, and when
A new round usually means Ikonisys is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ikonisys raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ikonisys, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ikonisys. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ikonisys raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ikonisys raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.